Takeda was named Pharma Company of the Year at the 2019 Scrip Awards in London on December 4. The company was recognized for accelerating its transformation through the acquisition of Shire, and sharpened focus on core therapeutic areas and advancement in clinical pipeline through external partnership. Diversity and inclusion efforts, and transparency with stakeholders, investors and the media were also highly praised.
